Of interest, serum levels of IGF1 and IGFBP3 are reduced in the DMSXL mouse model of DM1 (165) but it is not known whether supplementing with IGF1 or increasing its expression would rescue the impairment in muscle function seen in this model. The gene discussed is IGF1; the disease is myotonic dystrophy type 1.